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Abstract. 
 
In this report we examine the biological and 
molecular basis of the control of sympathetic neuron 
differentiation and survival by NGF and neurotrophin-3 
(NT-3). NT-3 is as efficient as NGF in mediating neuri-
togenesis and expression of growth-associated genes in 
NGF-dependent sympathetic neurons, but it is 20–40-
fold less efficient in supporting their survival. Both 
NT-3 and NGF induce similar sustained, long-term ac-
tivation of TrkA, while NGF is 10-fold more efficient 
than NT-3 in mediating acute, short-term TrkA activ-
ity. At similar acute levels of TrkA activation, NT-3 still 
mediates neuronal survival two- to threefold less well 
than NGF. However, a mutant NT-3 that activates 
TrkC, but not TrkA, is unable to support sympathetic 
neuron survival or neuritogenesis, indicating that NT-
3–mediated TrkA activation is necessary for both of 
these responses. On the basis of these data, we suggest 
that NGF and NT-3 differentially regulate the TrkA re-
ceptor both with regard to activation time course and 
downstream targets, leading to selective regulation of 
neuritogenesis and survival. Such differential respon-
siveness to two ligands acting through the same Trk re-
ceptor has important implications for neurotrophin 
function throughout the nervous system.
 
T
 
he
 
 neurotrophic factor hypothesis postulates that
interactions between a developing peripheral neu-
ron and its target organ play an essential role in
neuronal competition and cell death. This hypothesis is
perhaps best exemplified by developing sympathetic neu-
rons, which are absolutely dependent upon NGF, one
member of the neurotrophin family of growth factors (7,
28, 42, 47), during the period of target competition (9, 43–
45, 62). During this developmental window that occurs
neonatally, NGF is believed to bind to its cognate recep-
tors on the terminals of sympathetic neurons and to regu-
late their afferent input density via two primary mechanisms.
First, NGF stimulates arborization and synaptogenesis via
appropriate input neurons. Secondly, NGF serves as a dis-
criminating mechanism that allows the elimination of neu-
rons that have failed to sequester adequate target territory.
This latter function is accomplished by an NGF-induced
signal transduction cascade that prevents neuronal apop-
tosis (19, 20).
Target-derived NGF initiates these responses by bind-
ing to two different cell surface receptors: the tyrosine ki-
nase receptor TrkA (33, 34, 36), a member of the Trk fam-
ily of receptors (2), and the p75 neurotrophin receptor
(12). TrkA binds preferentially to NGF, but it can also
bind the structurally related neurotrophin-3 (NT-3)
 
1
 
 (47)
in 3T3 fibroblasts (15), while the p75 receptor binds all of
the neurotrophins (56, 57). It is clear from studies on cul-
tured neurons that NGF binding to TrkA alone is suffi-
cient to mediate many of the prototypic biological re-
sponses (31). Moreover, all sympathetic neurons are lost
in TrkA 
 
2
 
/
 
2
 
 mice (61), as they are in NGF 
 
2
 
/
 
2
 
 mice (16).
However, the p75 receptor likely also plays a role since re-
cent evidence indicates that it modulates TrkA tyrosine ki-
nase activity (3, 71), that it signals on its own to modulate
ceramide (22, 23) and NF
 
k
 
B (10), and, finally, that there
are deficits in sympathetic innervation in the p75 
 
2
 
/
 
2
 
mice (41).
Although the vast majority of sympathetic neurons have
an absolute requirement for NGF during the period of tar-
get competition, three different lines of evidence indicate
that these neurons may well “see” other cellular sources of
neurotrophins, and that these other neurotrophins may
play important biological roles. First, neurotrophins are
made by Schwann cells (1, 30, 49), and sympathetic neu-
rons themselves express both brain-derived neurotrophic
factor (BDNF) and NT-3 mRNAs (60), raising the possi-
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bility of autocrine/paracrine interactions. Secondly, al-
though neonatal sympathetic neurons do not respond to
NT-3 with survival, as do their embryonic counterparts (8,
21), they express high affinity NT-3 binding sites (18);
TrkC mRNA, which encodes the preferred Trk receptor
for NT-3 (40), is expressed at low levels in the neonatal su-
perior cervical ganglion (SCG). Finally, NT-3 
 
2
 
/
 
2
 
 mice
have 50% fewer sympathetic neurons (25, 26, 66) and dis-
play deficits in sympathetic target innervation that can be
rescued by exogenous NT-3 (24).
In this paper we demonstrate that NT-3 only very poorly
supports the survival of NGF-dependent neonatal sympa-
thetic neurons, but that when survival is maintained by
limiting quantities of NGF, NT-3 selectively mediates neu-
ritogenesis and expression of genes associated with mor-
phological growth. We have examined the biochemical
basis of this differential biological responsiveness. Sympa-
thetic neurons express relatively high levels of the TrkA
receptor and low levels of the TrkC receptor. NGF acti-
vates TrkA in a graded fashion, while NT-3 activates TrkA
and, to a much lesser extent, TrkC. Both of these neu-
rotrophins induce similar sustained activation of TrkA,
while NGF is 10-fold more efficient than NT-3 in mediat-
ing short-term TrkA activity. This TrkA activation is nec-
essary for NT-3 to mediate sympathetic neuron survival
and neuritogenesis, as demonstrated using a mutant NT-3
that activates only TrkC. However, even at similar acute
levels of TrkA activation, NT-3 mediates neuronal sur-
vival at levels two- to threefold less well than NGF. These
data suggest that NGF and NT-3 differentially regulate the
TrkA receptor both with regard to activation time course
and downstream targets, leading to selective regulation of
neuritogenesis and survival. Such differential responsive-
ness to two ligands acting through the same Trk receptor
has important implications for neurotrophin function
throughout the nervous system. 
 
Materials and Methods
 
Primary Neuronal Cultures
 
Mass cultures of pure sympathetic neurons from the SCG of postnatal day
1 rats were prepared as previously described (46). Neurons were plated on
rat tail collagen-coated tissue-culture dishes: 4-, 12-, or 24-well plates (Fal-
con Labware, Becton Dickinson & Co., Lincoln Park, NJ) for neurite ex-
tension assays, 6-well plates for biochemistry, and 48-well plates for MTT
assays. Low density SCG cultures for neurite extension assays were coated
with poly-
 
d
 
-lysine and laminin (both from Collaborative Biomedical
Products, Bedford, MA). For gene induction and protein analysis,
 
z
 
300,000 cells were plated per well of a 6-well dish.
In a few experiments, the neurons were cultured directly in 30 ng/ml
NT-3 or BDNF, but, in the vast majority, NGF-dependent neurons were
selected by culturing for 5 d in the presence of 10 ng/ml NGF. For survival
assays, at the end of this 5-d selection, neurons were washed once for two h
in neurotrophin-free media, and then fed with 400 
 
m
 
l of neurotrophin-
containing media. Analysis of survival was performed 48 h later by using
nonradioactive cell proliferation (MTT) assays (Celltitre 96; Promega,
Madison, WI). 20 
 
m
 
l of the MTT reagent was added to each well and left
for 90 min, followed by the addition of 200 
 
m
 
l of solubilization solution to lyse
the cells. Each condition was repeated in quadruplicate. In each assay, base-
line (0% survival) was considered 0 ng/ml NGF, and 10 ng/ml was consid-
ered 100% survival. All other conditions were related to these values.
For neurite extension assays, after 5 d, the neurons were switched into
media containing 10 ng/ml NGF plus or minus the appropriate other neu-
rotrophin. For the short-term biochemistry experiments, the medium was
changed to L15 medium plus 0.1% BSA on the day of the experiment, left
on for 3 h, and changed again 45 min before the induction began. Neu-
rotrophin was then added to the cultures for 10 min, the medium was de-
canted off, and the cells were stored on ice. Each well was rinsed once
with cold TBS, and 0.5–1.0 ml of lysis buffer was added. For the long-term
biochemistry experiments, the medium was switched on day 5 to medium
containing 10 ng/ml NGF plus the appropriate additional neurotrophin.
Lysis was performed as described for the short-term experiments.
 
Analysis and Quantification of Process Outgrowth
 
Analysis of the effects of neurotrophins on neuronal growth was exam-
ined by measuring three parameters: process network density, total neu-
rite length, and cell body area. The quantitative analysis of cell process
density on high and low density cultures was performed using common
statistics applied to random sets of lines, in particular the number of inter-
section points per unit area. In the microscope, the network of neural pro-
cesses appears as a random set of lines in a plane. The number of visible
cross-links and bifurcations of cell processes per unit area can therefore be
considered as a quantitative measure of the cell process density. However,
since the number of neurites is a direct function of the number of neurons,
only those regions in the culture having a similar cell density are compara-
ble. Thus, in each experiment, 10–15 sampling windows (10 mm
 
2
 
) were an-
alyzed, each containing seven neuronal cell bodies. All interceptions and
bifurcations of neurites within these windows were counted, resulting in
an estimated value of neuritic process density. Statistical comparison of
the mean values of density was performed using ANOVA (F-test).
Total neurite length and cell body area were measured in low density
cultures within defined areas controlled for cell body number. Results
were analyzed both within groups of sister cultures with different treat-
ments and by pooling results of similar treatments from different groups
of sister cultures. Similar results were obtained, and the pooled data are
therefore presented. The 
 
t
 
 test and ANOVA were used to determine sta-
tistical significance.
 
RNA Preparation and Northern Blot Analysis
 
Total cytoplasmic RNA was collected from cultured neurons as described
previously (46). Equal amounts of RNA (1–5 
 
m
 
g) were electrophoresed
on a 1.2% agarose-formaldehyde gel, transferred to nitrocellulose, and
probed with a 
 
32
 
P-labeled antisense RNA probe for T
 
a
 
1 
 
a
 
-tubulin, p75
neurotrophin receptor, or tyrosine hydroxylase, as previously described
(46). To confirm that equal amounts of RNA were loaded in each lane,
ethidium bromide was added to the sample buffer before electrophoresis.
Results were quantitated using scanning laser densitometry.
 
PCR Analysis and Sequencing
 
Total RNA was isolated from adult rat brain, liver, neonatal SCG, and
cultured rat sympathetic neurons as described above. cDNAs were syn-
thesized by reverse transcription using the SuperScriptII reverse tran-
scriptase kit (GIBCO BRL, Gaithersburg, MD). PCR amplification was
carried out on cDNAs using the following oligonucleotide primers specific
for the intracellular domain of TrkC: 5
 
9
 
-GAGGATTTTGTAGATC-3
 
9
 
and 5
 
9
 
-CCACGCCAGGCCAAGG-3
 
9
 
 as well as a set of pan-trk primers:
5
 
9
 
-TACGGTCGACGGTCCAAA-3
 
9
 
 and 5
 
9
 
-TGGCTTGTGGCAATT-
GTG-3
 
9
 
. Taq DNA polymerase and nucleotides were obtained from
Promega. The PCR products were subcloned into the PCR-II vector using
the TA Cloning Kit (Invitrogen, San Diego, CA). Random insert-contain-
ing clones were sequenced with the Sanger dideoxy protocol, using the Se-
quenase DNA Sequencing Kit (Amersham Corp., Arlington Heights, IL).
 
Antibodies
 
Anti-TrkCin2 was generated in rabbits using a peptide derived from the
intracellular portion of rat TrkC, amino acids 88–108. This region of TrkC
is distinct from the other Trk family members, but conserved amongst spe-
cies. Anti-TrkCout is directed against the extracellular domain of TrkC and
is described in Kaplan et al. (34). Although both of these antibodies are
effective for Western blots, neither immunoprecipitates. For immunopre-
cipitations, we used anti-TrkA antibody RTA (14), anti-pan Trk antibody
203 (29), two different immunoprecipitating anti-TrkC antibodies that are
described in Tsoulfas et al. (68), and anti-p75 antibody MC192 (11). For
Western blots, we also used anti-TrkCin2 (as described above), anti-phos-
photyrosine (UBI, Lake Placid, NY), and a rabbit anti–p75 antibody di-
rected against the intracellular domain of the rat p75 neurotrophin recep-
tor (the kind gift of P. Barker, McGill University, Montreal, Canada). 
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Immunoprecipitation and Western Blot Analysis
 
Sympathetic neurons were lysed in TBS lysis buffer (38) containing 137 mM
NaCl, 20 mM Tris (pH 8.0), 1% (vol/vol) NP-40, 10% (vol/vol) glycerol,
1 mM PMSF, 10 
 
m
 
g/ml aprotinin, 0.2 
 
m
 
g/ml leupeptin, 5 mM Phenanthro-
line, and 1.5 mM sodium vanadate. For anti-pan Trk and anti-p75 immu-
noprecipitations, one well of a 6-well dish was lysed in 1 ml of buffer,
while, for anti-TrkA or anti-TrkC immunoprecipitations, each of two
wells was lysed in 500 
 
m
 
l and combined. The cells were rocked for 20 min
at 4
 
8
 
C, scraped, and collected in microfuge tubes. Each sample was vor-
texed for 10 s, and then cleared by centrifugation. The lysates were nor-
malized for protein concentration using a BCA protein assay reagent
(Pierce Chemical Co., Rockford, IL). Total Trk protein was immunopre-
cipitated using 3 
 
m
 
l of anti-pan Trk 203, TrkA using 2 
 
m
 
l of anti-TrkA
RTA, TrkC using 3 
 
m
 
l each of two TrkC-specific antibodies, and p75 neu-
rotrophin receptor using 3 
 
m
 
l of antibody MC192. The immunoprecipi-
tates were collected with protein A–Sepharose (Pharmacia, Uppsala, Swe-
den) for 1.5 h at 4
 
8
 
C followed by centrifugation. In some experiments,
glycosylated proteins were precipitated from cell lysates with wheat germ
lectin-agarose as described (35, 38).
For Western blot analysis, precipitates were washed three times with
cold lysis buffer, boiled in sample buffer (2% SDS, 100 mM DTT, 10%
glycerol, and 0.05% bromophenol blue) for 5 min, and electrophoresed on
8.0% SDS polyacrylamide minigels. For experiments characterizing the
biochemical specificity of Trk antibodies, lysates of Sf9 cells expressing
equivalent quantities of mammalian TrkA, TrkB, or TrkC were probed in
Western blotting experiments with Trk antibodies. After electrophoresis,
proteins were transferred to 0.2-
 
m
 
m nitrocellulose for 1 h at 0.5 A, and the
membranes were washed twice (10 min each) in TBS. For all antibodies
except anti-phosphotyrosine, for which membranes were blocked in 2%
BSA (Sigma Chemical Co., St. Louis, MO), membranes were blocked in
5% nonfat dry milk in TBS for 2.5 h. Membranes were then washed twice
(10 min each) in TBS, and the primary antibodies were used overnight at
4
 
8
 
C at dilutions of 1:5,000 for anti-phosphotyrosine, 1:1,000 or 1:2,000
Figure 1. NGF-dependent sympathetic neurons respond to NT-3 but not to BDNF. Phase-contrast micrographs of cultures of pure sym-
pathetic neurons from the postnatal day 1 rat SCG maintained in 10 ng/ml NGF for 5 d (A) and then supplemented with 30 ng/ml NT-3
(B) or 30 ng/ml BDNF (C). NT-3 enhanced the number of neurites compared with BDNF when examined 2 d after addition. In similar
cultures where the NGF was replaced with 30 ng/ml BDNF (D), obvious cell body and process deterioration was evident. 
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for anti-pan Trk 203, 1:2,000 for anti-p75, and 1:2,000 for TrkCin2. Mem-
branes were incubated in secondary antibody for 1.5 h at room tempera-
ture, and antibodies were used at dilutions of 1:10,000 or 1:20,000 for a
goat anti–mouse HRP antibody (Boehringer Mannheim Biochemicals, In-
dianapolis, IN; used for anti-phosphotyrosine), 1:10,000 for a goat anti–
rabbit HRP antibody (Boehringer Mannheim Biochemicals; used for anti-
TrkA, anti-TrkC, and anti-p75), and 1:2,000 for protein A–HRP (Sigma
Chemical Co; used for anti-pan Trk). Detection was carried out using en-
hanced chemiluminescence (Amersham Corp.) and XAR x-ray film
(Eastman Kodak Co., Rochester, NY). Results were quantitated by scan-
ning laser densitometry.
 
Cultured Cell Lines
 
PC12 cell lines (27) were propagated in DME (GIBCO BRL) supple-
mented with 6% bovine calf serum and 6% horse serum in 100-mm tissue-
culture plates (Falcon Labware) at 7% CO
 
2
 
 in a 37
 
8
 
C chamber. Sf9 cells
were infected with recombinant baculovirus vectors expressing human
TrkA (65), rat TrkB (72), and rat TrkC (68) as described (65).
 
Results
 
NT-3 Selectively Promotes Neurite Extension in
NGF-dependent Sympathetic Neurons
 
To determine whether sympathetic neurons responded to
either NT-3 or BDNF after they become dependent upon
target-derived NGF, we selected the NGF-dependent pop-
ulation of neonatal sympathetic neurons by culturing in 10
ng/ml NGF for 5 d (Fig. 1 
 
A
 
) and examined neurotrophin-
mediated survival and neurite extension. To assay for sur-
vival responses, after selection in NGF, neurons were
switched to 30 ng/ml NT-3 or BDNF. BDNF was not suffi-
cient to support the survival of NGF-dependent neurons;
by 2 d after the switch, all of the neurons in the cultures
were dead, as monitored by counting phase-bright cell
bodies (Fig. 1 
 
D
 
). In contrast, 25–30 ng/ml NT-3 was suffi-
cient to support the survival of a small population of NGF-
dependent neurons (Fig. 2 
 
A
 
).
To quantitate the level of neuronal survival in NT-3 rel-
ative to NGF, we used MTT assays that measure mito-
chondrial function (Fig. 2 
 
A
 
). NGF-dependent sympa-
thetic neurons were selected in 10 ng/ml NGF for 5 d,
switched to varying concentrations of NGF or NT-3, and
assayed 2 d after the switch. NGF mediated the survival of
sympathetic neurons over a concentration range of 1.25–
10 ng/ml; 1.25 ng/ml NGF maintained 
 
z
 
20% survival, 2.5
ng/ml 40–45% survival, 5.0 ng/ml 60–65% survival, and 10
ng/ml 100% survival. NT-3 maintained survival 
 
z
 
20–40-
fold less efficiently than NGF; 10 ng/ml NT-3 maintained
10–15% survival, 25 ng/ml 
 
z
 
20%, 50 ng/ml 
 
z
 
25%, and
100 ng/ml 
 
z
 
40%. A comparison of these survival curves
indicated that 25 ng/ml NT-3 was roughly equivalent to
1.25 ng/ml NGF, and 100 ng/ml NT-3 to 2.5 ng/ml NGF.
To determine whether NT-3 or BDNF addition could
 
Figure 2.
 
(
 
A
 
) NT-3 is 20–40-fold less efficient than NGF at supporting survival of NGF-dependent sympathetic neurons. Results of a
colorimetric MTT assay to measure mitochondrial function and cell survival. Neonatal sympathetic neurons were cultured in 10 ng/ml
NGF for 5 d in 48-well dishes, washed free of neurotrophin-containing medium, and then incubated for 2 d in various concentrations of
NGF and/or NT-3, as indicated on the x axis. Each point represents the values pooled from three independent sets of survival assays,
each of which was performed in quadruplicate. In these assays, absolute values are normalized so that the value obtained with 0 neu-
rotrophin is 0% survival, while that obtained with 10 ng/ml NGF (in which the neurons were originally selected) is considered 100% sur-
vival. Error bars represent SEM; * 
 
5
 
 
 
P
 
 
 
, 
 
0.05, ** 
 
5
 
 
 
P
 
 
 
, 
 
0.01, and *** 
 
5
 
 
 
P
 
 
 
, 
 
0.001. For NGF and NT-3 alone, comparisons were made
using a 
 
t
 
 test with the 0 neurotrophin control. For the NGF/NT-3 combinations, comparisons were made against the survival supported
by the same concentrations of NGF (
 
no brackets
 
) and NT-3 (
 
brackets
 
) alone. (
 
B–D
 
) NT-3 is equivalent to NGF in mediating neurito-
genesis of NGF-dependent sympathetic neurons. (
 
B
 
) Three separate experiments were performed to determine the effect of NT-3 or
BDNF on process outgrowth in sympathetic neurons. Sympathetic neurons were plated at moderate density on a collagen substrate,
selected in 10 ng/ml NGF for 5 d, and then supplemented with either 30 ng/ml NT-3 or BDNF as indicated. The number of fields exam-
ined for each point ranged from 9–14. In all three experiments, significantly more neurite intersections were observed after exposure to 30
ng/ml NT-3 plus 10 ng/ml NGF (*** 
 
5
 
 
 
P
 
 
 
, 
 
0.001) than 10 ng/ml NGF alone. (
 
C
 
 and 
 
D
 
) To confirm the results presented in 
 
B
 
, and to di-
rectly compare NT-3 to NGF, neurons were plated at low density on a poly-
 
d
 
-lysine/laminin substrate, selected in 10 ng/ml NGF for 5 d,
and then either maintained in 10 ng/ml NGF or switched to 30 ng/ml NGF or to 10 ng/ml NGF plus 30 ng/ml NT-3. Two independent ex-
periments were performed, and 8–12 fields were quantitated per treatment in each experiment. The results of the two experiments were
pooled. (
 
C
 
) 2–2.5-fold more neurite intersections were observed after exposure to either 30 ng/ml NGF or to 10 ng/ml NGF plus 30 ng/
ml NT-3 than after exposure to 10 ng/ml NGF alone (*** 
 
5
 
 
 
P
 
 
 
, 
 
0.001). These NGF- and NT-3–induced increases were statistically similar
to each other (
 
P
 
 
 
5
 
 0.45). (
 
D
 
) Total neurite length was also significantly increased after exposure to 30 ng/ml NGF or to 10 ng/ml NGF
plus 30 ng/ml NT-3, relative to 10 ng/ml NGF (*** 
 
5
 
 
 
P
 
 
 
, 
 
0.001). Again, the increase was statistically similar for 30 ng/ml NGF vs 10 ng/
ml NGF plus 30 ng/ml NT-3 (
 
P
 
 
 
5
 
 0.28). (
 
E
 
) NGF is more effective than NT-3 at mediating cell body hypertrophy. Cell body size of sym-
pathetic neurons was quantitated in the experiments described in 
 
C
 
 and 
 
D.
 
 In this case, NT-3 elicited a small but statistically significant
increase of 
 
z
 
10%, whereas 30 ng/ml NGF led to an 
 
z
 
25% hypertrophy of the sympathetic neuron cell bodies (** 
 
5
 
 
 
P
 
 
 
, 
 
0.01, *** 
 
5
 
 
 
P
 
, 
 
0.001). The hypertrophy observed in 10 ng/ml NGF plus 30 ng/ml NT-3 was significantly different from that seen in 30 ng/ml NGF (
 
P
 
5
 
 0.0006). (
 
F
 
 and 
 
G
 
) Recombinant mutant NT-3 that activates TrkC but not TrkA is insufficient to support sympathetic neuron survival
(
 
F
 
) or neuritogenesis (
 
G). (F) Results of a colorimetric MTT assay to measure mitochondrial function and cell survival in response to
NGF, NT-3, or a mutant NT-3 that binds only TrkC (mut. NT-3) (58, 59). Sympathetic neurons were cultured in 10 ng/ml NGF for 5 d,
washed free of neurotrophin-containing media, and then incubated for 2 d in various concentrations of neurotrophins, as indicated on
the x axis. Each point represents the values pooled from three independent sets of survival assays, each of which was performed in qua-
druplicate. Growth of sympathetic neurons in 50 or 100 ng/ml mutant NT-3 resulted in significantly less survival than 100 ng/ml NT-3
(*** 5 P , 0.001). In these assays, absolute values are normalized with regard to NGF-mediated survival, as described for A. (G) To
compare sympathetic neuron process outgrowth in response to mutant NT-3 that activates only TrkC (mut. NT-3), neurons were cul-
tured in 10 ng/ml NGF for 5 d, and then maintained for an additional 2 d in 10 ng/ml NGF plus or minus 30 ng/ml NT-3 or mutant NT-3.
Two independent experiments were performed, and eight fields were quantitated per treatment. As shown in D, total neurite length was
significantly increased after exposure to 10 ng/ml NGF plus 30 ng/ml NT-3, relative to 10 ng/ml NGF alone (*** 5 P , 0.0005). In con-
trast, no increase in neurite length was observed with mutant NT-3 addition relative to 10 ng/ml NGF alone (P 5 0.14).Belliveau et al. Differential Regulation by Neurotrophins 379The Journal of Cell Biology, Volume 136, 1997 380
mediate neurite extension independent of survival, sympa-
thetic neurons were plated on collagen and selected in 10
ng/ml NGF for 5 d, and then 30 ng/ml NT-3 or BDNF was
added in the presence of 10 ng/ml NGF for an additional 2 d.
The addition of NT-3 led to a robust increase in the den-
sity of neuritic processes (Fig. 1 B), with a 2- to 2.5-fold in-
crease in neuritic density in each of the three separate ex-
periments (Fig. 2 B). In contrast, addition of 30 ng/ml
BDNF had no measurable effect (Figs. 1 C and 2 B).
To more precisely define the effect of NT-3 on neurito-
genesis, sympathetic neurons were plated at low density
on poly-d-lysine/laminin, selected for 5 d in 10 ng/ml NGF,
and then switched to 10 ng/ml NGF plus 30 ng/ml NT-3, or
to 30 ng/ml NGF. 2 d later, the process network density,
total neurite length, and cell body size were all measured.
As seen in the higher density cultures (Fig. 2 B), the pro-
cess network density was increased 2- to 2.5-fold in the
presence of 10 ng/ml NGF plus 30 ng/ml NT-3 (Fig. 2 C).
A statistically similar increase was noted with 30 ng/ml
NGF. Similar results were obtained from measurements of
total neurite length; both NT-3 and NGF mediated an
z1.5-fold increase (Fig. 2 D). In contrast, NGF and NT-3
differentially regulated cell body size (Fig. 2 E). Neurons
cultured in 10 ng/ml NGF plus 30 ng/ml NT-3 displayed a
small but significant (P 5 0.002) increase of z10%,
whereas neurons cultured in 30 ng/ml NGF hypertrophied
z25–30%, an increase that was significantly greater than
that obtained with NGF plus NT-3 (P , 0.001). Thus, al-
though NT-3 was approximately equivalent to NGF in its
ability to promote neurite extension, it was significantly
less effective in promoting cell body hypertrophy, and it
was 20–40-fold less efficient at promoting neuronal sur-
vival.
NT-3 Enhances Survival of NGF-dependent 
Sympathetic Neurons
The regulation of neurite extension by both NGF and NT-3
raised the possibility that, while NT-3 on its own only
poorly supported survival, it might enhance survival in the
presence of limiting quantities of NGF. To test this possi-
bility, neurons were first cultured in 10 ng/ml NGF for 5 d,
and then were switched into a variety of concentrations of
NGF and/or NT-3 (Fig. 2 A). 1.25 ng/ml NGF plus 25 ng/ml
NT-3, each of which support z20% survival, together sup-
ported z35% neuronal survival. Similarly, 2.5 ng/ml NGF
plus 50 ng/ml NT-3, which support z40% and 25% neu-
ronal survival, respectively, together supported z65% sur-
vival. Finally, 2.5 ng/ml NGF plus 100 ng/ml NT-3, each of
which support z40% survival, together supported 75%
neuronal survival. Thus, NT-3 can enhance, in an approxi-
mately additive fashion, the survival of NGF-dependent
sympathetic neurons when quantities of NGF are limiting.
NT-3 Selectively Induces Growth-associated
Gene Expression
We have previously demonstrated that, in neonatal sym-
pathetic neurons, NGF regulates the expression of the
mRNAs encoding tyrosine hydroxylase, p75 neurotrophin
receptor, and Ta1 a-tubulin in a graded, concentration-
dependent fashion (46). To determine whether NT-3 regu-
lated gene expression as it does neurite extension, sympa-
thetic neurons were selected in 10 ng/ml NGF for 5 d, 10 or
30 ng/ml NT-3 was added in addition to 10 ng/ml NGF,
and RNA was isolated at time points ranging from 6–48 h
after addition. Northern blot analysis revealed that the ad-
dition of 30 ng/ml NT-3 for 6 h led to a 5- to 10-fold in-
crease in Ta1 a-tubulin mRNA (Fig. 3 A), one member of
the a-tubulin multigene family whose expression is regu-
Figure 3. NT-3 selectively regulates expression of genes associ-
ated with morphological growth in a concentration-dependent
fashion. (A) Expression of Ta1 a-tubulin mRNA (Ta1) in equal
amounts of total RNA isolated from neonatal sympathetic neu-
rons cultured for 5 d in the presence of 10 ng/ml NGF (lane 1) fol-
lowed by addition of 30 ng/ml NT-3 for 6 h (lane 2), 24 h (lane 3),
or 48 h (lane 4). (B and C) Expression of tyrosine hydroxylase
(TH) (B) and p75 neurotrophin receptor (p75) (C) mRNAs in re-
sponse to the addition of 30 ng/ml NT-3 for 6 , 12, or 24 h. In all
panels, lane 1 includes total RNA from neurons maintained for the
entire time in 10 ng/ml NGF, while lane 2 includes an equal amount
of total RNA isolated from sister cultures treated with 10 ng/ml
NGF plus 30 ng/ml NT-3. (D) Expression of Ta1 a-tubulin, tyro-
sine hydroxylase, and p75 neurotrophin receptor mRNAs after
24 h of treatment with 10 ng/ml NGF (lane 1), 10 ng/ml NGF plus
30 ng/ml NT-3 (lane 2), or 10 ng/ml NGF plus 10 ng/ml NT-3
(lane 3). Lane 4 for Ta1 mRNA contains an equal amount of total
RNA isolated from neurons treated with 200 ng/ml NGF for 24 h.Belliveau et al. Differential Regulation by Neurotrophins 381
lated as a function of neuronal growth (48, 50, 51). This in-
crease was maintained at 24 and 48 h, consistent with the
robust increase in neuritic process density induced by NT-3
addition, and was concentration dependent: 10 ng/ml NT-3
elicited no significant increase in Ta1 a-tubulin mRNA
(Fig. 3 D). The magnitude of the increase observed with 30
ng/ml NT-3 was similar to that observed upon addition of
200 ng/ml NGF (Fig. 3 D). We have previously demon-
strated that levels of Ta1 mRNA increase in a concentra-
tion-dependent fashion with increasing levels of NGF to
plateau at 100–200 ng/ml (46). Thus, 30 ng/ml NT-3 was
capable of eliciting as large an increase in Ta1 mRNA as
saturating quantities of NGF. In contrast with NT-3, the
addition of 30 ng/ml BDNF had no effect on expression of
Ta1 a-tubulin mRNA (data not shown).
The addition of 30 ng/ml NT-3 also led to a smaller, ap-
proximately two- to threefold increase in the expression of
tyrosine hydroxylase mRNA (Fig. 3 B). This increase,
which was not elicited by 10 ng/ml NT-3 (Fig. 3 D), was
first observed at 6 h, and was subsequently maintained for
48 h. Addition of BDNF had no effect on expression of ty-
rosine hydroxylase mRNA (data not shown).
In contrast with Ta1 a-tubulin and tyrosine hydroxylase
mRNAs, NT-3 had a lesser effect on the expression of p75
neurotrophin receptor mRNA (Fig. 3 C) with an z1.5- to
2-fold increase after 24 h in the presence of 30 but not 10
ng/ml NT-3. This reduced response is particularly striking
given that increased NGF induces a robust increase in ex-
pression of p75 receptor mRNA in sympathetic neurons in
culture and in vivo (46, 50, 53). A similar difference was
noted at the protein level (see Fig. 6 F). p75 receptor levels
were increased approximately two- to threefold in neurons
cultured in 10 ng/ml NGF plus 30 ng/ml NT-3, whereas 40
and 100 ng/ml NGF led to increases of z5-fold and 15-
fold, respectively. Thus, NT-3 was equivalent to NGF in
inducing expression of Ta1 a-tubulin mRNA, but was less
effective at inducing expression of the p75 neurotrophin
receptor.
The NGF-dependent Population of
Neonatal Sympathetic Neurons Express Low Levels of 
Full-Length, Kinase Domain–intact TrkC
Neonatal, NGF-dependent sympathetic neurons express
both TrkA and the p75 neurotrophin receptor. To deter-
mine whether they also express the TrkC receptor, we per-
formed Western blot analysis. To perform these studies,
an anti-peptide antibody was generated against sequences
from the intracellular domain of the full-length TrkC re-
ceptor. The specificity of this antibody was assessed by
Western blot analysis of lysates of Sf9 insect cells express-
ing human TrkA, rat TrkB, or rat TrkC (Fig. 4 A). This
anti-peptide antibody, anti-TrkCin2, recognized only rat
TrkC and not human TrkA or rat TrkB expressed in Sf9
cells (Fig. 4 A, left), while anti-pan Trk antibody 203 (29)
recognized all three Trk receptors (Fig. 4 A, right). To en-
sure that anti-TrkCin2 also did not recognize rat TrkA,
PC12 cell lysates were immunoprecipitated with anti-pan
Trk 203, and the precipitates were analyzed on Western
blots. Anti-TrkCin2 did not recognize rat TrkA from PC12
cells, while anti-pan Trk 203 did (data not shown).
To determine whether NGF-dependent sympathetic neu-
rons express full-length TrkC protein, they were cultured
for 5 d in 10 ng/ml NGF, and then glycosylated proteins in
the cellular lysates were precipitated using WGA. Western
blot analysis of these WGA precipitates with anti-TrkCin2
revealed the presence of an immunoreactive protein of
145 kD, the size of full-length TrkC (Fig. 4 B). Confirma-
tion that this band represented bona fide TrkC was ob-
tained using a second antibody that is specific to the extra-
cellular domain of TrkC (anti-TrkCout; data not shown).
This second antibody, which recognizes both truncated
and full-length TrkC, detected little or no truncated TrkC
in the cellular lysates.
TrkC is an alternatively spliced protein, with some of
the splice variants encoding proteins with kinase domain
inserts (40, 67, 69). To determine whether the full-length
TrkC expressed by NGF-dependent sympathetic neurons
contained a kinase insert, we sequenced across the kinase
domain in seven independent TrkC clones isolated from
these cells by reverse transcriptase–PCR. In all cases, the
clones represented TrkC mRNAs with intact kinase do-
mains. Similarly, PCR analysis across the kinase domain
demonstrated that only non–insert-containing TrkC mRNA
could be amplified in RNA from cultured sympathetic
neurons, while insert-containing TrkC mRNA could be
easily amplified in RNA isolated from rat brain under the
same conditions (data not shown). Thus, NGF-dependent
sympathetic neurons express full-length, non–insert-con-
taining TrkC.
Levels of the TrkC receptor were, however, very low
relative to the TrkA receptor, as previously reported (8,
21). TrkA was easily detectable by Northern blots (Toma,
J., D. Rogers, D. Senger, R. Campenot, and F. Miller,
manuscript submitted for publication), immunocytochem-
Figure 4. Full-length TrkC is expressed in NGF-dependent sym-
pathetic neurons. (A, left) Specificity of the anti-TrkCin2 anti-
body, which recognizes the intracellular domain of TrkC, was
tested by probing lysates of insect cells expressing human TrkA,
rat TrkB, or rat TrkC on Western blots. (A, right) Anti-pan Trk
antibody 203 recognizes all three Trk family members on a simi-
lar Western blot. (B) Western blot analysis of full-length TrkC in
NGF-dependent sympathetic neurons as detected by probing
WGA precipitates with anti-TrkCin2. Lane 1 includes protein
from sympathetic neurons cultured for 5 d in 10 ng/ml NGF, and
lane 2 includes protein from sister cultures induced with 30 ng/ml
NT-3 for 10 min. The immunoreactive TrkC band is detected at
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istry (39), and Western blots of anti-pan Trk immunopre-
cipitates (see Fig. 6 E), while TrkC was difficult to detect
using these same techniques (data not shown; see Fig. 6 E).
NT-3 Preferentially Induces TrkA Autophosphorylation 
in Sympathetic Neurons
These studies indicated that NGF-dependent sympathetic
neurons express two Trk receptors that might be responsi-
ble for mediating the functional effects of NT-3: relatively
high levels of TrkA, and low levels of full-length, kinase-
intact TrkC. To determine whether either of these two re-
ceptors was activated by NT-3, we analyzed Trk receptor
autophosphorylation in response to neurotrophin addi-
tion. Specifically, sympathetic neurons were selected for 5 d
in 10 ng/ml NGF, washed for 3 h in neurotrophin-free me-
dia, and then treated with varying concentrations of NGF
and/or NT-3 for 10 min. Cell lysates were quantitated with
Figure 5. (A–D) NT-3 expo-
sure leads to the autophos-
phorylation of both TrkA
and TrkC on NGF-depen-
dent sympathetic neurons.
Neonatal sympathetic neu-
rons were cultured for 5 d in
10 ng/ml NGF, washed for 3 h
in neurotrophin-free media,
and then induced with neu-
rotrophins for 10 min. Cell
lysates were immunoprecipi-
tated (IP) with either anti-pan
Trk 203 (pantrk), anti-TrkA,
or anti-TrkC. Immunopre-
cipitates were analyzed by
Western blot analysis with
anti-phosphotyrosine or anti-
pan Trk 203 as the primary
antibodies (18Ab). All sam-
ples were normalized for
equal amounts of protein.
(A) Trk autophosphorylation
increased in a graded fashion
in response to 10 ng/ml NGF,
and in response to 30 ng/ml
NGF, relative to base line
levels of autophosphoryla-
tion with 0 NGF. (Numbers,
left) Molecular weight mark-
ers; (Trk) size of the Trk
band. (B) Trk autophosphor-
ylation in sympathetic neu-
rons in response to varying
concentrations of neurotro-
phins. Note the presence of a
single autophosphorylated
Trk band in the samples
treated with NT-3. (C) TrkA
and TrkC autophosphoryla-
tion in response to NGF
vs NT-3. Approximately
300,000 neurons were lysed
and analyzed for TrkA-spe-
cific autophosphorylation in
response to no neurotrophin
addition, 10 ng/ml NGF, or
30 ng/ml NT-3. The same ly-
sates were then immunopre-
cipitated for TrkC-specific
autophosphorylation in re-
sponse to 10 ng/ml NGF or 30 ng/ml NT-3. Note that the right two lanes containing the TrkC immunoprecipitates are both from the
same autoradiograph of the same gel. (D) The same immunoprecipitates as in C were probed with anti-pan Trk on a separate Western
blot to ensure that approximately equal amounts of TrkA were present in each sample. (E) TrkA in PC12 cells is not autophosphory-
lated in response to NT-3. PC12 cells were induced with NGF and/or NT-3 for 10 min, and cellular lysates were immunoprecipitated
with anti-pan Trk 203, followed by a Western blot with anti-phosphotyrosine.Belliveau et al. Differential Regulation by Neurotrophins 383
regards to protein concentration, and levels of Trk recep-
tor autophosphorylation were determined by immunopre-
cipitation of lysates with anti-pan Trk, followed by West-
ern blot analysis with anti-phosphotyrosine. Blots were
subsequently reprobed with anti-pan Trk to ensure that
equal amounts of Trk protein were present in all samples,
and both phosphotyrosine and Trk protein levels were
quantitated from these blots densitometrically. These ex-
periments demonstrated that NGF addition from 10–100
ng/ml resulted in graded increases in TrkA autophosphor-
ylation over the entire concentration range (Fig. 5 A; data
not shown), consistent with the biological response curve
we have previously documented (46).
Similar experiments revealed that 30 ng/ml NT-3 also
led to increased Trk receptor autophosphorylation on
NGF-dependent sympathetic neurons. When 30 ng/ml
NT-3 and 10 ng/ml NGF were added together, a small but
significant increase in Trk autophosphorylation was ob-
served relative to 10 ng/ml NGF alone (Fig. 5 B). In con-
trast, 30 ng/ml NT-3 plus 30 ng/ml NGF resulted in a level
of Trk autophosphorylation similar to that induced by 30
ng/ml NGF alone. Interestingly, 100 ng/ml NT-3 was capa-
ble of eliciting short-term Trk autophosphorylation at lev-
els comparable to 10 ng/ml NGF (Fig. 5 B), even though it
was approximately two- to threefold less efficient at induc-
ing neuronal survival (Fig. 2 A).
To determine whether the NT-3-induced increase in Trk
autophosphorylation was due to TrkA and/or TrkC activa-
tion, we used antibodies specific to TrkA or TrkC for im-
munoprecipitation, followed by Western blot analysis with
anti-phosphotyrosine. These studies revealed that a 10-
min treatment of NGF-dependent sympathetic neurons
with 30 ng/ml NT-3 alone was sufficient to induce auto-
phosphorylation of TrkA at levels z2.5-fold lower than
10 ng/ml NGF (Fig. 5 C). Western blotting of the same
samples with a pan Trk antibody confirmed that the level
of Trk protein was similar, within 25%, in each lane (Fig. 5 D).
A similar, more detailed analysis revealed that 30 ng/ml
NT-3 elicited approximately the same level of short-term
TrkA autophosphorylation as did 2.5 ng/ml NGF (data not
shown), a 10-fold difference that is similar to that observed
for NT-3 vs NGF on total Trk autophosphorylation (Fig. 5 B).
Similar experiments using TrkC-specific antibodies for
immunoprecipitation revealed that 30 ng/ml NT-3 also led to
tyrosine phosphorylation of the 145-kD TrkC band (Fig. 5
C, TrkC IP lanes). In contrast to NT-3, treatment with 10
ng/ml NGF had no effect on TrkC activity (Fig. 5 C). Thus,
NT-3 led to autophosphorylation of both TrkC and TrkA.
In contrast with sympathetic neurons, when PC12 cells
were treated with 30 ng/ml NT-3 for 10 min, no autophos-
phorylation of TrkA was observed (Fig. 5 E), in agreement
with previous findings (32). Moreover, when 30 ng/ml NT-3
was added in the presence of 10 ng/ml NGF, TrkA auto-
phosphorylation was not increased above the level ob-
tained with 10 ng/ml NGF alone (Fig. 5 E).
NT-3–mediated Sympathetic Neuron Survival and 
Neuritogenesis Requires TrkA Activation
These data indicated that NT-3 activated TrkA and, to a
lesser degree, TrkC on NGF-dependent sympathetic neu-
rons. To determine which of these two receptors mediated
the observed biological responses to NT-3, we used a mu-
tant NT-3 that binds to TrkC but not to TrkA (58, 59). As
reported, when fibroblasts expressing either TrkA or
TrkC were exposed to 30 ng/ml of this mutant NT-3, TrkC
but not TrkA was autophosphorylated. When, instead, the
same fibroblasts were exposed to 30 ng/ml NT-3, both
TrkA and TrkC were autophosphorylated (data not
shown).
To determine whether activation of TrkC alone was suf-
ficient to mediate survival, sympathetic neurons were cul-
tured for 5 d in 10 ng/ml NGF, and then were switched to
varying concentrations of NGF, NT-3, or mutant NT-3 for
2 d. Quantitation of neuronal survival using MTT assays
revealed that the mutant NT-3 was incapable of eliciting
significant levels of neuronal survival at concentrations of
up to 100 ng/ml (Fig. 2 F), while 100 ng/ml NT-3 mediated
z45% survival. These data therefore indicate that TrkA
activation is necessary for NT-3–mediated survival of sym-
pathetic neurons.
To determine whether activation of TrkA was also nec-
essary for NT-3–mediated neuritogenesis, sympathetic neu-
rons were cultured at low density for 5 d in 10 ng/ml NGF,
and then were maintained for an additional 2 d in 10 ng/ml
NGF plus or minus 30 ng/ml NT-3 or mutant NT-3. Quan-
titation of total neurite length per cell body (Fig. 2 G) re-
vealed that, as seen in previous experiments (Fig. 2 D),
NT-3 caused an increase in total neurite outgrowth that
was significantly greater than NGF alone (P , 0.0005). In
contrast, the amount of neurite outgrowth observed in
NGF plus mutant NT-3 was similar to that observed with
NGF alone. Thus, TrkA activation was also necessary for
NT-3–mediated neuritogenesis.
Differences in Acute and Sustained TrkA Activation in 
Response to NGF vs NT-3
Together, these results indicated that NGF, acting through
TrkA, mediated sympathetic neuron survival and neurito-
genesis, whereas NT-3, also acting at TrkA, was 20–40-fold
less efficient at mediating survival, but equally effective at
inducing neuritogenesis. Moreover, even when NT-3 was
used at concentrations that elicited levels of short-term
TrkA autophosphorylation that were similar to NGF, it
was two- to threefold less effective in maintaining neu-
ronal survival. One potential explanation for these results
is that NGF-mediated Trk activation is more sustained
than NT-3–mediated activation. To address this possibil-
ity, neurons were selected in 10 ng/ml NGF for 5 d, and
then were switched for an additional 2 d to either 40 ng/ml
NGF or to 30 ng/ml NT-3 plus 10 ng/ml NGF. Anti-pan
Trk immunoprecipitations of cellular lysates followed by
probing with anti-phosphotyrosine revealed that 30 ng/ml
NT-3 plus 10 ng/ml NGF resulted in levels of long-term to-
tal Trk autophosphorylation that were similar to 40 ng/ml
NGF (Fig. 6 A). Moreover, in both conditions, the Trk
autophosphorylation was greatly increased above that ob-
tained with 10 ng/ml NGF alone (Fig. 6 A), which was it-
self sustained at higher levels than when neurons were
washed free of neurotrophins for several hours (data not
shown). These results were very different from those ob-
served after 10 min of induction, when the level of total
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plus 10 ng/ml NGF was much lower than that with 30 ng/ml
NGF, and was only slightly increased relative to 10 ng/ml
NGF (Fig. 5 B).
To determine whether the differences in the time course
of Trk autophosphorylation in response to NGF vs NT-3
were due to activation of TrkA vs TrkC, similar experi-
ments were performed using the TrkA-specific antibody.
Western blot analysis of anti-TrkA immunoprecipitates
with anti-phosphotyrosine revealed that, as observed for
total Trk autophosphorylation, 30 ng/ml NT-3 plus 10 ng/ml
NGF was as efficient at sustaining TrkA autophosphoryla-
tion as was 40 ng/ml NGF (Fig. 6 C). Moreover, both of
these conditions led to much higher TrkA autophosphory-
lation than did 10 ng/ml NGF, a pattern that was again
Figure 6. (A–D) NT-3 in-
duces a prolonged autophos-
phorylation of TrkA equiva-
lent to that induced by NGF.
Neonatal sympathetic neu-
rons were cultured for 5 d in
10 ng/ml NGF, and then
switched to neurotrophin-
containing media for an addi-
tional 2 d. Cellular lysates
were immunoprecipitated
(IP) either with anti-pan Trk
or anti-TrkA. Immunopre-
cipitates were then analyzed
by Western blot analysis with
anti-phosphotyrosine or anti-
pan Trk (18Ab). All samples
were normalized for equal
amounts of protein. (A) Trk
autophosphorylation in re-
sponse to 2 d of constant ex-
posure to NGF and/or NT-3.
Note that all three of these
lanes are from the same au-
toradiograph of the same
Western blot. (B) NGF and
NT-3 do not alter Trk recep-
tor levels in sympathetic neu-
rons. In two separate experi-
ments, total Trk levels in
NGF-dependent sympa-
thetic neurons were similar
regardless of neurotrophin-
treatment, as evidenced
when neurons are cultured in
various concentrations of
NGF, NT-3, and/or BDNF
for 2 d. (C) TrkA autophos-
phorylation in response to 2 d
of constant exposure to
NGF and/or NT-3. (D) The
same immunoprecipitates as
in C were probed with anti-
pan Trk on a separate West-
ern blot to ensure that ap-
proximately equal amounts
of TrkA were present in each
sample. (E) NGF and NT-3
do not alter TrkA or TrkC
levels. To determine whether
TrkA or TrkC levels changed
with increased levels of neu-
rotrophins, NGF-dependent
sympathetic neurons were cultured for 48 h in various concentrations of NGF and/or NT-3. Lysates were immunoprecipitated with the
anti-pan Trk antibody, and then analyzed by Western blots with antibodies specific to TrkA or TrkC. The appropriately sized Trk bands
are indicated by arrows. (F) NGF and NT-3 alter the ratio of Trk/p75 in NGF-dependent sympathetic neurons. After immunoprecipita-
tion with anti-pan Trk, the lysates shown in B were immunoprecipitated for the p75 neurotrophin receptor using the mAb MC192. Im-
munoprecipitates were then probed on a Western blot with a polyclonal anti-p75 antibody.Belliveau et al. Differential Regulation by Neurotrophins 385
very distinct from that observed at short time points (Fig.
5 C). Western blot analysis of the same immunoprecipita-
tions with the pan Trk antibody confirmed that similar
amounts of TrkA protein were present in each sample
(Fig. 6 D). Thus, although 30 ng/ml NT-3 led to only a low
level of TrkA autophosphorylation in the short term and
would not mediate survival of these neurons, it was as effi-
cient at sustaining long-term TrkA autophosphorylation
as 30 ng/ml NGF.
To ensure that the differences between long-term and
short-term Trk autophosphorylation profiles were not due
to alterations in Trk receptor levels in the long-term ex-
periments, 5-d-old NGF-dependent neurons were switched
to a variety of concentrations of NGF and/or NT-3 for 48 h,
and Trk levels were assessed by Western blot analysis of
anti-pan Trk immunoprecipitates with the pan Trk anti-
body. These studies revealed that levels of Trk protein
were constant over this time course, irrespective of the
concentration of NGF added and/or the presence of NT-3
or BDNF (Fig. 6 B). To confirm this result, cell lysates
were immunoprecipitated with a pan Trk antibody, fol-
lowed by Western blot analysis with TrkA- or TrkC-spe-
cific antibodies. As observed for total Trk protein levels,
the addition of 100 ng/ml NGF or NT-3 for 2 d had no ef-
fect on TrkA or TrkC levels (Fig. 6 E).
In contrast, levels of the p75 neurotrophin receptor var-
ied considerably as a function of the level of NGF and/or
NT-3. As previously reported for the mRNA (46, 52), lev-
els of p75 protein were dramatically increased by concen-
trations of NGF ranging from 10–110 ng/ml (Fig. 6 E). Sig-
nificant but smaller increases occurred with the addition of
30 or 100 ng/ml NT-3 to 10 ng/ml NGF (Fig. 6 E), consis-
tent with the small changes in mRNA levels (Fig. 3 C).
Thus, although Trk levels remained constant, variations in
neurotrophin exposure resulted in alterations in the p75/
Trk receptor ratio, as previous reported in vivo (53).
Discussion
The data presented in this paper support a number of con-
clusions. First, we demonstrate that NT-3 is as effective as
NGF in mediating neuritogenesis and growth-associated
gene expression in NGF-dependent sympathetic neurons,
but it is 20–40-fold less efficient at supporting their sur-
vival. NGF is also considerably more effective than NT-3
at mediating cell body hypertrophy and induction of the
p75 neurotrophin receptor. Second, we demonstrate that
sympathetic neurons respond to NGF from 10–100 ng/ml
with graded increases in TrkA autophosphorylation. This
concentration curve correlates precisely with our previ-
ously published biological response curve (46). Third, these
studies surprisingly indicate that NT-3 exposure leads to
autophosphorylation of TrkA at concentrations that do
not activate TrkA in a PC12 cell environment. At short ex-
posure time points, NGF is z10-fold more efficient than
NT-3 at inducing TrkA autophosphorylation, but, when
exposure is maintained for 48 h, the activation obtained in
response to NT-3 is equivalent to that elicited by NGF.
Moreover, NT-3, at concentrations that elicit short-term
Trk autophosphorylation similar to that induced by NGF,
mediates survival approximately two- to threefold less ef-
ficiently than NGF. Fourth, we demonstrate that NGF-
dependent sympathetic neurons express full-length, kinase
domain–intact TrkC that is also autophosphorylated in re-
sponse to NT-3, albeit at low levels relative to TrkA. Fifth,
although NT-3 leads to both TrkA and TrkC activation, it
is apparently the TrkA activation that is essential for neu-
ronal survival and neuritogenesis. Finally, long-term expo-
sure to NGF and NT-3 does not alter either TrkA or TrkC
levels in sympathetic neurons, although it does lead to dif-
ferences in the p75/Trk receptor ratio. Together, these
data indicate that NGF and NT-3 differentially regulate
the survival and differentiation of NGF-dependent sympa-
thetic neurons while activating the same Trk receptor. 
Evidence presented here indicates that the NGF-induced
graded biological response curve previously documented
for NGF-dependent sympathetic neurons (46) can be com-
pletely explained on the basis of graded increases in TrkA
activation. These graded increases in TrkA autophosphor-
ylation occur at concentrations of NGF varying from 1
(Belliveau, D., and F.D. Miller, unpublished data) to 100
ng/ml. At the low end of this curve (1–10 ng/ml), the first
response to be elicited is neuronal survival. On a per neu-
ron basis, the survival response is clearly a step-function
and likely occurs at a given threshold of TrkA activation.
Once the survival threshold is reached, neurite outgrowth
and gene expression are then regulated in a graded fashion
as a function of receptor activation over the concentration
range from 10–100 ng/ml. Although the breadth of this
dose–response curve may seem somewhat surprising, it is
very similar to that observed in PC12 cells that are overex-
pressing the TrkA receptor (29) (Kaplan, D., unpublished
observations). Biologically, such an extended concentra-
tion curve makes sense; during the period of target inner-
vation, neurons need to sequester a small amount of NGF
to ensure their survival, but, thereafter, they are con-
fronted with innervating an increasingly large target area
as the animal grows (see 54), necessitating graded regula-
tion of the neuronal growth response.
The more surprising result is the selectivity of the NT-3–
mediated neuronal response, as demonstrated here. NGF
elicits survival, neuritogenesis, cell body hypertrophy, and
induction of Ta1 a-tubulin and p75 receptor mRNAs. In
contrast, NT-3 mediates neuritogenesis and induction of
Ta1 mRNA as effectively as NGF, but only poorly elicits
survival, cell body hypertrophy, and p75 receptor induc-
tion. A number of pieces of evidence presented here indi-
cate that NT-3 mediates these responses by activating
TrkA. First, total TrkA levels are much higher than TrkC
levels on sympathetic neurons, and the pattern of total Trk
activation stimulated by NT-3 is essentially identical to
that seen for TrkA. Second, and most importantly, selec-
tive activation of TrkC, using an NT-3 mutant that does
not bind to TrkA (58), does not mediate survival or neuri-
togenesis, indicating that TrkA activation is necessary for
these two NT-3–mediated responses. Further support for
this conclusion derives from recent data indicating that
TrkA activation is sufficient to maintain the survival of
sympathetic neurons derived from TrkC 2/2 mice (17).
Thus, NGF and NT-3, both of which predominantly acti-
vate TrkA in NGF-dependent sympathetic neurons, as
shown here, mediate different biological responses.
Why does NT-3 activate TrkA in a sympathetic neuron,
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a transformed cell line that is the “nearest neighbor” to
sympathetic neurons? Sympathetic neurons express only
the insert-containing form of the TrkA receptor (Barker, P.,
and F. Miller, unpublished observations) (4, 13), which is
preferentially activated by NT-3 (13). However, since PC12
cells also express the same TrkA receptor variant (4, 13),
the difference in responsiveness to NT-3 must be a func-
tion of the cellular environment. In fact, a number of lines
of evidence indicate that the p75 receptor may be respon-
sible. In fibroblasts that do not express p75, the TrkA re-
ceptor is activated by NT-3 at relatively low concentra-
tions (37, 64). In PC12 cells that have lost most of their p75
receptor (6) and in PC12 cells that overexpress TrkA (29),
NT-3 also activates TrkA. Thus, it appears that, when the
p75/TrkA receptor ratio is low, NT-3 acts at TrkA, but,
when this ratio is high, NT-3 is excluded from TrkA. The
fact that the ratio of p75/TrkA is z10-fold higher in PC12
cells than it is in a sympathetic neurons (73) is consistent
with this explanation.
Since NGF and NT-3 both function through TrkA to
mediate sympathetic neuron survival and neuritogenesis,
then what is the reason for the selectivity of the NT-3 re-
sponse relative to NGF? We suggest that these two neu-
rotrophins differentially regulate the TrkA receptor both
with regard to activation time course and downstream tar-
gets. In support of this hypothesis, we provide evidence
that the profile of TrkA activation differs for these two
factors. In the short term, NGF is z10-fold better than
NT-3 at stimulating TrkA autophosphorylation, while, in
the long term, NT-3 is as effective as NGF. However, in
spite of the equivalent sustained TrkA signaling, NGF and
NT-3 mediate different responses. This is in contrast with
the model of differential signaling by mitogenic and differ-
entiation factors for PC12 cells. This hypothesis proposes
that sustained signaling elicits neurite outgrowth, while
transient signaling elicits cell proliferation (55). In studies
reported here, NGF and NT-3 mediate different biological
responses while both stimulating sustained TrkA activa-
tion. The differences in biological responses seen here may
instead be due to NGF inducing a strong acute TrkA acti-
vation that does not occur with NT-3.
We also suggest that differential activation of TrkA by
NGF and NT-3 may lead to differing profiles of down-
stream substrate activation, and that NT-3 may simply not
activate pathways essential to survival as efficiently as NGF
does. Support for this hypothesis derives from the obser-
vation that, when NT-3 and NGF are used at concentra-
tions that elicit equivalent short-term TrkA activation, NGF
is still approximately two- to threefold better at maintain-
ing neuronal survival. Thus, differences in absolute levels
of short-term activation are not sufficient by themselves to
fully explain the differential biological responsiveness.
This hypothesis, that NGF and NT-3 differentially acti-
vate TrkA to mediate differing neuronal responses, does
not exclude the potential involvement of the TrkC and p75
receptors. Although our data indicate that TrkA activa-
tion is necessary for NT-3–mediated survival and neurito-
genesis, it is still formally possible that simultaneous acti-
vation of low levels of TrkC with TrkA may somehow
“dampen” certain aspects of TrkA-mediated signaling. We
consider this possibility unlikely, and suggest that the p75
neurotrophin receptor is much more likely to play such a
modulatory role (53). If the liganded p75 receptor signals,
as recent data suggests (10, 22, 23), to mediate apoptosis
(5) (Miller, F., and P. Barker, unpublished observations),
then the ultimate survival of a neuron may depend upon
the relative activation of TrkA vs p75 receptors. Since NT-3
binds less efficiently to TrkA than NGF, and more effi-
ciently to the p75 receptor than NGF (57), it may well be
that the TrkA signal induced by NT-3 is insufficient, in this
cellular context, to override the p75-driven signal, thereby
resulting in neuronal death. We have, in fact, obtained re-
cent data demonstrating that, in low amounts of NGF, se-
lective activation of the p75NTR leads to sympathetic neu-
ron apoptosis (Belliveau, D., S. Bamji, M. Majdan, R.
Aloyz, C. Pozniak, J. Kohn, C. Causing, and F.D. Miller,
manuscript submitted for publication).
Together with the data derived from the NT-3 2/2 mice
(25), these experiments indicate that NT-3 is essential for
the normal development of sympathetic neurons and pro-
vide insights into the cellular mechanisms whereby it me-
diates its effects. During neurogenesis and before target
contact, sympathetic neurons express relatively high levels
of TrkC and relatively low levels of TrkA, and respond to
NT-3 with survival (8, 21, 70, 73). Since NT-3 is expressed
within the sympathetic ganglia during this developmental
window, potentially in sympathetic neurons themselves (60),
there may be a TrkC-mediated autocrine/paracrine loop that
participates in regulating neuronal number and survival
before target contact. As sympathetic neurons become post-
mitotic and extend their axons toward their targets, TrkA
levels greatly increase and TrkC levels greatly decrease (8,
21), coincident with the onset of NGF dependency. Devel-
opment of an absolute requirement for target-derived NGF
provides a cellular mechanism for establishing the appro-
priate target innervation density: if sympathetic neurons
still responded to NT-3 with survival, this would subvert
the competition. Instead, our data suggest that only those
neurons that successfully compete for target-derived NGF
would be competent to respond to NT-3, which would
then make them more “fit” to compete for additional tar-
get territory. We suggest that the developmental differ-
ence in responsiveness to NT-3 is a consequence of the de-
velopmental switch in receptor repertoire: NT-3 signaling
through TrkC in sympathetic neuroblasts mediates sur-
vival, while NT-3 signaling through TrkA in postmitotic
neurons selectively mediates neuritogenesis. Is there any
evidence that such a hypothesis is true in vivo, given that
NT-3 only mediates neuritogenesis at concentrations of 30
ng/ml in culture? In fact, a recent report by El-Shamy et al.
(24) demonstrates that NT-3 is necessary for appropriate
sympathetic target innervation in vivo. In transgenic animals
carrying one functional copy of the NT-3 gene (NT-3 1/2
mice), certain sympathetic targets are insufficiently inner-
vated, a deficit that can be rescued by administration of
exogenous NT-3. 
Thus, even the prototypic NGF-dependent sympathetic
neurons, which display an absolute dependence upon
NGF during the period of target competition, differen-
tially respond to two neurotrophins that activate the same
Trk receptor. Such biochemical convergence and func-
tional cross talk of several neurotrophins at one Trk recep-
tor could provide a partial explanation for the differences
noted between Trk receptor vs neurotrophin gene knock-Belliveau et al. Differential Regulation by Neurotrophins 387
outs (63). Thus, neuronal interdependence on multiple
neurotrophins, acting through one Trk receptor, may be
the rule rather than the exception.
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